Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer

International Journal of Artificial Organs

Volumn 33, Issue 3, 2010, Pages 147-153

  Matsumura, Masaki ^a   Sasaki, Hisako ^a   Sekizuka, Kumiko ^a   Sano, Hiroyuki ^a   Ogawa, Kouji ^a   Shimizu, Chihiro ^a   Yoshida, Hiroaki ^a   Kobayashi, Satsuki ^a   Koremoto, Masahide ^b   Aritomi, Masaharu ^b   Ueki, Kazue ^a  

^a Toho Hospital   (Japan)

^b Asahi Kasei Medical Co   (Japan)

Author keywords

Hemodialysis; Intradialytic hypotension; Nitric oxides; Vitamin E bonded dialyzer

Indexed keywords

BIOCOMPATIBILITY; BLOOD PRESSURE; HEMODIALYZERS; NITRIC OXIDE;

BASELINE VALUES; CLINICAL TRAITS; DIALYZER MEMBRANES; HAEMODIALYSIS; HIGH FLUX; INTRADIALYTIC HYPOTENSION; PILOT STUDIES; POLYSULPHONE; VITAMIN E-BONDED DIALYZER; VITAMIN-E;

DIALYSIS;

CELLULOSE TRIACETATE; NITRIC OXIDE; POLY(METHYL METHACRYLATE); POLYSULFONE; ALPHA TOCOPHEROL; ANTIOXIDANT; BIOMATERIAL; POLYMER; POLYSULFONE P 1700; SULFONE;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD LEVEL; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; HYPOTENSION; INTRADIALYTIC HYPOTENSION; KIDNEY FAILURE; MALE; PULSE PRESSURE; PULSE RATE; SYSTOLIC BLOOD PRESSURE; VITAMIN E BONDED POLYSULFONE MEMBRANE DIALYZER; CHEMISTRY; MIDDLE AGED; PILOT STUDY; RENAL REPLACEMENT THERAPY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERS; RENAL DIALYSIS; SULFONES; VITAMIN E;

EID: 77951097961     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300303     Document Type: Article

References (29)

1. Landry DW, Oliver JA. Blood pressure instability during hemodialysis. Kidney Int 2006; 69: 1833-1838
2. Chou KJ, Lee PT, Chen CL, et al. Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int 2006; 69: 1833-1838
3. Ligtenberg G. Regulation of blood pressure in chronic renal failure: determinants of hypertension and dialysis-related hypotension. Neth J Med 1999; 55: 13-18
4. Orofino L, Marcén R, Quereda C, et al. Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am J Nephrol 1990; 10: 177-180
5. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38 (Suppl 4): S11-7.
6. Sato M, Horigome I, Chiba S, et al. Autonomic insufficiency as a factor contributing to dialysis-induced hypotension. Nephrol Dial Transplant 2001; 16: 1657-1662
7. Morena M, Cristol JP, Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif 2000; 18: 191-199
8. Aslam S, Santha T, Leone A, Wilcox C. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int 2006; 70: 2109-2115
9. Madore F, Prud'homme L, Austin JS, et al. Impact of nitric oxide on blood pressure in hemodialysis patients. Am J Kidney Dis 1997; 30: 665-671
10. Nishimura M, Takahashi H, Maruyama K, et al. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis. Am J Kidney Dis 1998; 31: 809-817
11. Raj DS, Vincent B, Simpson K, et al. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int 2002; 61: 697-704.
12. Mochizuki S, Ono J, Yada T, et al. Systemic nitric oxide production rate during hemodialysis and its relationship with nitric oxide-related factors. Blood Purif 2005; 23: 317-324
13. Sarkar SR, Kaitwatcharachai C. Levin NW. Nitric oxide and hemodialysis. Semin Dial 2004; 17: 224-228
14. Kang ES, Tevlin MT, Wang YB, et al. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period. Am J Med Sci 1999; 317: 9-21.
15. Erkan E, Devarajan P, Kaskel F. Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis 2002; 40: 76-81.
16. Sasaki M, Hosoya N, Saruhashi M. Vitamin E modified cellulose membrane. Artif Organs 2000; 24: 779-789
17. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 1998; 54: 580-589
18. Galli F: Vitamin E-modified dialyzers. Contrib Nephrol 2002; 137: 95-105.
19. Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant 2006; 21: 2825-2833
20. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007; 43: 4-15.
21. Cruz DN, de Cal M, Ronco C. Oxidative stress and anemia in chronic hemodialysis: the promise of bioreactive membranes. Contrib Nephrol 2008; 161: 89-98.
22. Kojima K, Oda K, Homma H, et al. Effect of vitamin E-bonded dialyzer on eosinophilia in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 1932-1935
23. Noiri E, Yamada S, Nakao A, et al. Serum protein acrolein adducts: utility in detecting oxidant stress in hemodialysis patients and reversal using a vitamin E-bonded hemodialyzer. Free Radic Biol Med 2002; 33: 1651-1656
24. Satoh M, Yamasaki Y, Nagake Y, et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 2001; 59: 1943-1950
25. Cruz DN, De Cal M, Garzotto F, et al. Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study. Int J Artif Organs 2008; 31: 545-552
26. Clark WR, Gao D. Properties of membranes used for hemodialysis therapy. Semin Dial 2002; 15: 191-195
27. Floridi A, Piroddi M, Pilolli F, Matsumoto Y, Aritomi M, Galli F. Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater 2009; 5: 2974-2982
28. Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in hemodialysis patients. Nephrol Dial Transplant 2005; 20: 2775-2782
29. Ohta K, Araki N, Shibata M, et al. A novel in vivo assay system for consecutive measurement of brain nitric oxide production combined with the microdialysis technique. Neurosci Lett 1994; 176: 165-168